Vaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2022 on November 29
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccine & Immunotherapy Congress West Coast 2022 in San Diego on Tuesday, November 29, 2022 at 1:50 p.m. PT / 4:50 p.m. ET.
Dr. Tucker will provide an overview of Vaxart’s Phase II trial for its oral pill COVID-19 vaccine candidate.
Vaxart recently announced positive top-line Phase II clinical study results for its Wuhan S-only COVID-19 pill vaccine candidate.
ITEXPO #TECHSUPERSHOW Pub Crawl on Expo Floor
Conference Luncheon - For Paid Conference Pass Holders, Exhibitors, Sponsors, Speakers, Press